Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mitral Valve Insufficiency | 6 | 2019 | 302 | 1.58 | Why? |
| Transcatheter Aortic Valve Replacement | 5 | 2019 | 839 | 1.02 | Why? |
| Ventricular Function, Left | 3 | 2019 | 1555 | 0.80 | Why? |
| Heart Valve Prosthesis Implantation | 3 | 2019 | 552 | 0.71 | Why? |
| Aortic Valve Stenosis | 4 | 2019 | 741 | 0.70 | Why? |
| Heart Valve Prosthesis | 3 | 2019 | 533 | 0.68 | Why? |
| Mitral Valve | 2 | 2018 | 342 | 0.64 | Why? |
| Ventricular Remodeling | 1 | 2018 | 349 | 0.57 | Why? |
| Heart Failure | 10 | 2021 | 6638 | 0.56 | Why? |
| Aortic Valve | 2 | 2019 | 664 | 0.55 | Why? |
| Stroke Volume | 3 | 2018 | 2153 | 0.53 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.40 | Why? |
| Prosthesis Design | 4 | 2019 | 594 | 0.36 | Why? |
| Cardiac Surgical Procedures | 2 | 2018 | 1931 | 0.32 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.31 | Why? |
| Quality of Life | 2 | 2020 | 9820 | 0.23 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.21 | Why? |
| Heart Rupture, Post-Infarction | 1 | 2020 | 74 | 0.21 | Why? |
| Registries | 3 | 2021 | 12327 | 0.21 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.21 | Why? |
| Heart Aneurysm | 1 | 2020 | 46 | 0.21 | Why? |
| Ventricular Dysfunction, Left | 2 | 2020 | 993 | 0.21 | Why? |
| ST Elevation Myocardial Infarction | 3 | 2021 | 3051 | 0.20 | Why? |
| Percutaneous Coronary Intervention | 4 | 2020 | 3646 | 0.19 | Why? |
| Ultrasonic Therapy | 1 | 2019 | 43 | 0.19 | Why? |
| Mechanical Thrombolysis | 1 | 2019 | 150 | 0.18 | Why? |
| Surgical Instruments | 1 | 2018 | 145 | 0.17 | Why? |
| Follow-Up Studies | 5 | 2018 | 17020 | 0.17 | Why? |
| Therapeutic Equivalency | 1 | 2017 | 64 | 0.17 | Why? |
| Pericardial Effusion | 1 | 2020 | 312 | 0.16 | Why? |
| Bioprosthesis | 1 | 2017 | 126 | 0.15 | Why? |
| Excipients | 1 | 2017 | 118 | 0.15 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.15 | Why? |
| Conservative Treatment | 1 | 2018 | 349 | 0.15 | Why? |
| Cardiomyopathy, Dilated | 1 | 2018 | 251 | 0.14 | Why? |
| Pericarditis | 1 | 2020 | 417 | 0.14 | Why? |
| Treatment Outcome | 11 | 2019 | 51732 | 0.14 | Why? |
| Italy | 8 | 2021 | 38444 | 0.14 | Why? |
| Coronary Stenosis | 1 | 2017 | 273 | 0.13 | Why? |
| Cardiology | 2 | 2020 | 2873 | 0.13 | Why? |
| Coronary Artery Disease | 2 | 2019 | 2570 | 0.13 | Why? |
| Pulmonary Edema | 1 | 2017 | 430 | 0.12 | Why? |
| Hemodynamics | 2 | 2019 | 1562 | 0.12 | Why? |
| Societies, Medical | 2 | 2020 | 6907 | 0.12 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.11 | Why? |
| Shock, Cardiogenic | 1 | 2017 | 700 | 0.10 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.10 | Why? |
| Aged, 80 and over | 9 | 2020 | 88759 | 0.09 | Why? |
| Coronary Angiography | 1 | 2019 | 2275 | 0.09 | Why? |
| Endovascular Procedures | 1 | 2019 | 1302 | 0.09 | Why? |
| Atrial Fibrillation | 2 | 2020 | 2320 | 0.09 | Why? |
| Renin-Angiotensin System | 2 | 2021 | 3661 | 0.09 | Why? |
| Acute Disease | 2 | 2019 | 6029 | 0.09 | Why? |
| Fibrinolytic Agents | 1 | 2019 | 1702 | 0.08 | Why? |
| Acute Coronary Syndrome | 1 | 2021 | 2107 | 0.08 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.08 | Why? |
| Angiotensin Receptor Antagonists | 2 | 2021 | 3892 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2019 | 2218 | 0.08 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.08 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.08 | Why? |
| Palliative Care | 1 | 2020 | 2665 | 0.07 | Why? |
| Humans | 28 | 2021 | 930598 | 0.07 | Why? |
| Aged | 12 | 2021 | 215776 | 0.07 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.07 | Why? |
| Female | 15 | 2021 | 380317 | 0.07 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.07 | Why? |
| Male | 14 | 2021 | 367725 | 0.07 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| Comorbidity | 4 | 2020 | 34796 | 0.07 | Why? |
| Retrospective Studies | 7 | 2019 | 105322 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Risk Factors | 6 | 2020 | 71621 | 0.05 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.05 | Why? |
| Renin | 1 | 2021 | 167 | 0.05 | Why? |
| Cachexia | 1 | 2020 | 75 | 0.05 | Why? |
| Aldosterone | 1 | 2021 | 155 | 0.05 | Why? |
| Hirudins | 1 | 2019 | 75 | 0.05 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2019 | 4775 | 0.05 | Why? |
| Angiotensins | 1 | 2021 | 259 | 0.05 | Why? |
| Peptide Fragments | 2 | 2020 | 2075 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.04 | Why? |
| Contraindications, Drug | 1 | 2019 | 281 | 0.04 | Why? |
| Thrombosis | 1 | 2019 | 7504 | 0.04 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.04 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.04 | Why? |
| Ventricular Function, Right | 1 | 2019 | 388 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.03 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.03 | Why? |
| Down-Regulation | 1 | 2020 | 1416 | 0.03 | Why? |
| Cardiology Service, Hospital | 1 | 2021 | 602 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Coronary Artery Bypass | 1 | 2019 | 629 | 0.03 | Why? |
| Stents | 1 | 2019 | 916 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2017 | 48226 | 0.03 | Why? |
| Tomography, Optical Coherence | 1 | 2019 | 1008 | 0.03 | Why? |
| Shock, Septic | 1 | 2020 | 1313 | 0.03 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2019 | 3786 | 0.02 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Frailty | 1 | 2020 | 1432 | 0.02 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Hemorrhage | 1 | 2019 | 3013 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.01 | Why? |